These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2303910)
21. Problems associated with the use of common names in the identification of poisonous plants. DiTomaso JM Vet Hum Toxicol; 1993 Oct; 35(5):465-6. PubMed ID: 8249273 [TBL] [Abstract][Full Text] [Related]
22. [Nomenclature of B6-vitamins and relative compounds. Preliminary rules]. Hoppe Seylers Z Physiol Chem; 1970 Oct; 351(10):1165-8. PubMed ID: 5479416 [No Abstract] [Full Text] [Related]
23. How to deal with nomenclatoral ambiguities of trivial names for natural products?--a clarifying case study exemplified for "corymbosin". Ramabharathi V; Schuehly W Nat Prod Commun; 2014 Jan; 9(1):57-60. PubMed ID: 24660463 [TBL] [Abstract][Full Text] [Related]
24. [Complexities of nomenclature in biology. Gender of generic names ending in ops z, n, (s) 1572]. Do Amaral A Mem Inst Butantan; 1975; 39():27-36. PubMed ID: 1235974 [No Abstract] [Full Text] [Related]
25. Abbreviations of generic names. SKINNER CE Science; 1946 Jul; 104(2690):62. PubMed ID: 20991767 [No Abstract] [Full Text] [Related]
27. Isoprostane nomenclature: inherent problems may cause setbacks for the development of the isoprostanoid field. Mueller MJ Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):71-81. PubMed ID: 20034775 [TBL] [Abstract][Full Text] [Related]
28. AFP policy on using generic and brand names for drugs. McCauley J Am Fam Physician; 2004 Sep; 70(6):1031-2; discussion 1032. PubMed ID: 15456112 [No Abstract] [Full Text] [Related]
29. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004. Kwo EC; Kamat P; Steinman MA Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956 [TBL] [Abstract][Full Text] [Related]
33. [Incompleteness of the present nomenclature of diseases and necessity for methodical instructions for using it]. OVCHAROV VK Sov Zdravookhr; 1957; 16(6):28-34. PubMed ID: 13455200 [No Abstract] [Full Text] [Related]
34. [Nomenclature of tuberculosis according to recent advances]. BOSZORMENYI M; SIRALYNE ST; VALKANYI R Tuberk Kerdesei; 1953 May; 6(2):15-9. PubMed ID: 13146832 [No Abstract] [Full Text] [Related]
35. International Nonproprietary Names (INN) for pharmaceutical substances. Kopp-Kubel S Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659 [TBL] [Abstract][Full Text] [Related]
36. A proposal for a new stereochemical notation for P-chiral nucleotide analogues and related compounds. Sobkowski M; Stawinski J; Kraszewski A Nucleosides Nucleotides Nucleic Acids; 2005; 24(9):1301-7. PubMed ID: 16252667 [TBL] [Abstract][Full Text] [Related]
37. Prescribing generic drugs using a generic name: Are we teaching it right? Kamath A Indian J Med Ethics; 2016; 1(3):194. PubMed ID: 27474700 [TBL] [Abstract][Full Text] [Related]
38. Artin M: a rational substitution for the names artocarpin and KM+. Pereira-da-Silva G; Roque-Barreira MC; Van Damme EJ Immunol Lett; 2008 Aug; 119(1-2):114-5. PubMed ID: 18602950 [TBL] [Abstract][Full Text] [Related]
39. [Observations on the international nomenclature of pulmonary segmentation]. KASSAY D Tuberk Kerdesei; 1954 Feb; 7(1):9-10. PubMed ID: 13205739 [No Abstract] [Full Text] [Related]
40. [IUPAC-IUB Commission on Biochemical Nomenclature. Preliminary rules. A letter notation for amino acid sequence]. Hoppe Seylers Z Physiol Chem; 1969 Jul; 350(7):793-7. PubMed ID: 5806553 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]